WO2025062365 - MESENCHYMAL LINEAGE PRECURSOR OR STEM CELLS (MLPSCS) FOR USE IN METHODS OF TREATING CONGENITAL HEART DISEASE
National phase entry:
Publication Number
WO/2025/062365
Publication Date
27.03.2025
International Application No.
PCT/IB2024/059175
International Filing Date
20.09.2024
Title **
[English]
MESENCHYMAL LINEAGE PRECURSOR OR STEM CELLS (MLPSCS) FOR USE IN METHODS OF TREATING CONGENITAL HEART DISEASE
[French]
PRÉCURSEUR DE LIGNÉE MÉSENCHYMATEUSE OU CELLULES SOUCHES MÉSENCHYMATEUSES (MLPSC) DESTINÉS À ÊTRE UTILISÉS DANS DES MÉTHODES DE TRAITEMENT D'UNE MALADIE CARDIAQUE CONGÉNITALE
Applicants **
MESOBLAST INTERNATIONAL SÁRL
Inventors
ITESCU, Silviu
BOROW, Kenneth M.
Priority Data
63/584,715
22.09.2023
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2893 | |
| EPO | Filing, Examination, Granting | 18753 | |
| Japan | Filing, Examination, Granting | 2811 | |
| South Korea | Filing, Examination, Granting | 3524 | |
| USA | Filing, Examination, Granting | 7340 |
Total:
35,321
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present disclosure relates to MLPSC mediated methods of treating congenital heart disease. Such methods may be particularly suitable for treating subjects with hypoplastic left heart syndrome.[French]
La présente invention concerne des méthodes médiées par MLPSC de traitement d'une maladie cardiaque congénitale. De tels procédés peuvent être particulièrement appropriés pour traiter des sujets atteints d'une hypoplasie du cœur gauche.